Physician profile
Nancy Lance
NPI 1356430417
$2,666.28
in general payments reported to CMS, 2019-2025
19 companies · $441 in 2025
The $441 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $525 · 2022: $878 · 2023: $218 · 2024: $604 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,263.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $417.24 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $381.13 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $327.82 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $307.66 | 2021-2024 | Airsupra |
| Sanofi-Aventis U.S. LLC | $244.81 | 2021-2022 | |
| Amgen INC. | $179.09 | 2021-2025 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.77 | 2021-2023 | Jardiance |
| Grifols USA, LLC | $124.99 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $113.86 | 2025 | Caplyta |
| Exact Sciences Corporation | $111.72 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $101.00 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $49.06 | 2021 | |
| Pfizer INC. | $39.20 | 2021-2024 | |
| Insulet Corporation | $23.85 | 2024 | Omnipod |
| Dexcom, INC. | $22.81 | 2025 | Dexcom G6 Transmitter |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $17.28 | 2021 | |
| Paratek Pharmaceuticals, INC. | $16.78 | 2025 | Nuzyra |
| Mylan Specialty L.P. | $15.64 | 2024 | Yupelri |
| Cranial Technologies, INC | $14.57 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Lance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.